CD19 and infection: A smaller number of patients (n = 9, 18%) CD19 CAR-T patients developed microbiologically confirmed infections (infection density of 0.091 infections per 100 patient-days-at-risk) within 1 year from cell infusion (Supplementary Figure 4), censoring at the time of relapse.